Table 2:
OR | 95 % CI | P value | |
---|---|---|---|
Clinical parameters | |||
Age, per unit change | 1.2 | 1.1 - 1.2 | <0.0001 |
Female | 2.9 | 0.8 - 10.4 | 0.09 |
AA vs Whites | 3.3 | 0.7 - 15.5 | 0.13 |
HTN | 3.6 | 0.8 - 16.9 | 0.10 |
DM | 2.0 | 0.6 - 7.2 | 0.27 |
CAD | 3.2 | 0.9 - 11.3 | 0.07 |
Smoking | 0.7 | 0.2 - 2.6 | 0.61 |
CHF | 1.6 | 0.7 - 3.6 | 0.30 |
Medications | |||
ASA | 2.4 | 0.7 - 8.5 | 0.15 |
Statin | 2.9 | 0.8 - 10.1 | 0.10 |
BB | 1.1 | 0.5 - 6.3 | 0.80 |
ACEi/ARB | 2.2 | 0.6 - 7.6 | 0.21 |
Diuretics | 1.2 | 0.1 - 9.3 | 0.87 |
Echocardiogram | |||
LVEF, per unit change | 0.9 | 0.9 - 1.0 | 0.15 |
LVEF <35% | 1.5 | 0.3 - 7.8 | 0.61 |
ESWS, per unit change | 1.0 | 1.0 - 1.0 | 0.01 |
EDWS, per unit change | 1.0 | 0.9 - 1.1 | 0.38 |
LV SV, per unit change | 0.9 | 0.9 – 1.0 | 0.27 |
LV EDV, per unit change | 1.0 | 0.9 – 1.0 | 0.97 |
Coronary Angiogram | |||
3 Vessel dis, % | 1.6 | 0.4 - 6.3 | 0.48 |
>50% LM stenosis | 14.1 | 3.5 - 56.8 | 0.02 |
Proximal LAD stenosis | 0.5 | 0.1 - 2.6 | 0.43 |
LVEDP, per unit change | 0.9 | 0.8 - 1.0 | 0.34 |
LVSP, per unit change | 1.0 | 0.9 - 1.1 | 0.06 |
AA, African American; HTN, hypertension; DM, diabetes mellitus; CHF, congestive heart failure; CKD, chronic kidney disease; STEMI, ST-elevation myocardial infarction; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin-receptor blocker; EDWS, end-diastolic wall stress; ESWS, end-systolic wall stress; LVEF, left ventricular ejection fraction; LM, left main; LAD, left anterior coronary artery; LV SV, LV stroke volume; LV EDV, LV end-diastolic volume; LVEDP, LV end-diastolic pressure; LVSP, LV systolic pressure.